Add like
Add dislike
Add to saved papers

1-AminoTriazole Transition-Metal Complexes as Laser-Ignitable and Lead-Free Primary Explosives.

This unique complex study describes two isomeric aminotriazoles as auspicious nitrogen-rich ligands for energetic coordination compounds (ECCs) to replace the commonly used highly poisonous and environmentally harmful lead-based primary explosives. The triazoles were obtained by easily scalable and convenient synthetic routes starting solely from commercially available starting materials. 1-Amino-1,2,3-triazole (1, 1-ATRI) and, for the first time, 1-amino-1,2,4-triazole (2, 1A-1,2,4-TRI) were employed as ligands to form highly energetic transition-metal(II) complexes. The desired characteristics could be altered successively by using various nonpoisonous metal(II) centers (Cu2+ , Mn2+ , Fe2+ , and Zn2+ ) and anions (Cl- , NO3 - , ClO3 - , ClO4 - , picrate, styphnate, 2,4,6-trinitro-3-hydroxyphenolate, and 2,4,6-trinitro-3,5-dihydroxyphenolate). The 14 synthesized coordination compounds were characterized comprehensively by XRD, IR and UV/Vis spectroscopy, elemental analysis, and differential thermal and thermogravimetric analyses. Ball-drop impact, electrostatic discharge (ESD), and mechanical (impact and friction) sensitivities were determined according to BAM standard methods. In addition to laser ignition experiments, selected ECCs were evaluated in classical secondary explosive initiation tests (detonators filled with pentaerythritol tetranitrate (nitropenta)), which revealed their enormous potential and proved them to be very attractive for future applications in explosives.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app